Therefore, in the present study, we evaluated the expression of TIM3 and galectin-9 in peripheral blood among healthy donors, patients with obesity, and obesity patients with newly diagnosed type 2 diabetes. This evidence concerns the gene HAVCR2 and type 2 diabetes mellitus.